On April 1, 2026, Ensysce Biosciences, Inc. announced the resignation of Curtis Rosebraugh from its Board of Directors, effective immediately. Dr. Rosebraugh had been serving on the Board and was a member of the Nominating and Corporate Governance Committee. The company confirmed that his resignation was not due to any disagreements with the management or the Board. This change in leadership may have implications for the company's governance structure, but it is not expected to have a significant impact on the company's operations or stock performance in the short term. The company continues to focus on its strategic initiatives and operational execution as it moves forward.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.